Shanghai Jeyou Pharmaceutical Technology Co., Ltd. was founded in 2018 in Pudong, Shanghai, and specializes in the research, development, manufacturing, and commercialization of innovative drugs. Leveraging its exceptional drug development capabilities and integrated R&D, manufacturing, and sales model, Jeyou Pharmaceutical is committed to rapidly bringing its proprietary innovative drugs to the global market to address unmet medical needs.
Guided by clinical value, Jeyou Pharma focuses on a “3+1” indication matrix encompassing oncology, nephrology, pain, and autoimmune diseases. The company has established specialized departments covering the entire drug development lifecycle and has built a comprehensive R&D system spanning basic research, preclinical studies, clinical trials, pharmacovigilance, and new drug registration and commercialization. Jeyou Pharma possesses multiple advanced technology platforms in the fields of large biomolecules and small chemical molecules. Led by scientists with extensive drug development experience, the R&D team identifies drug targets with unique clinical value and has mastered core R&D technologies and processes with proprietary intellectual property rights. Currently, there are over 40 projects in development, 19 of which have entered the clinical phase domestically and internationally.
Jeyou Pharma regards quality as the lifeblood of the company. To meet the market demand for high-quality innovative drugs, the company has established two state-of-the-art drug manufacturing bases in Hangzhou, Zhejiang, and Wuxi, Jiangsu. Integrating world-class pharmaceutical technologies and equipment, and guided by concepts such as QbD (Quality by Design) and and PDCA (Plan-Do-Check-Act), the company has established an internationally advanced quality management system compliant with ICH Q10. It implements full lifecycle control over all product manufacturing and supply chains, earning market and customer trust through product quality.
In mainland China, Jeyou Pharma has developed strong commercialization capabilities and is actively integrating into the global market, having successfully exported intellectual property rights for multiple innovative drugs. While contributing Chinese wisdom to human health, Jeyou Pharmaceuticals actively introduces internationally leading pharmaceuticals into the Chinese market to meet the country’s growing clinical needs.
Looking ahead, Jeyou Pharmaceuticals will continue to advance the development of innovative drugs, continuously build new productive forces, and strive to become an internationally advanced, modern, and innovative pharmaceutical enterprise, working tirelessly to improve human health!
2018
2018
Company Founding
Company Founding
40+
40+
Projects in Progress
Projects in Progress
19
19
Clinical Projects
Clinical Projects
Dedication, Expertise, Innovation, Entrepreneurship
Focusing on R&D to Build a Competitive Edge
Leverage the team’s proven track record of success
Innovation in Business Models and Management
An entrepreneurial spirit characterized by frugality, efficiency, and hard work
Jeyou Pharma has integrated ESG (Environmental, Social, and Governance) into a core component of its business strategy. We fully recognize that ESG is not only a manifestation of corporate social responsibility but also a key driver of sustainable corporate growth. Therefore, Jeyou Pharmaceuticals benchmarks against advanced international ESG standards and best practices. Focusing on five key dimensions—compliance and fairness, healthcare, social welfare, employee development, and green development—we are comprehensively and steadfastly advancing our ESG initiatives. We are continuously optimizing environmental management, enhancing social responsibility awareness, and strengthening corporate governance, striving tirelessly to achieve our goals of green, harmonious, and mutually beneficial development.